Galectin Therapeutics (GALT)
(Delayed Data from NSDQ)
$4.64 USD
+0.05 (1.09%)
Updated Sep 18, 2025 04:00 PM ET
After-Market: $4.67 +0.03 (0.65%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth A Momentum B VGM
Fundamental Charts
About Dividend Yield (TTM)
Galectin Therapeutics Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Drugs industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
GALT 4.64 +0.05(1.09%)
Will GALT be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for GALT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for GALT
Galectin Therapeutics Inc. (GALT) Is Up 7.48% in One Week: What You Should Know
Is ANI Pharmaceuticals (ANIP) Stock Outpacing Its Medical Peers This Year?
GALT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's Why Galectin Therapeutics (GALT) is Poised for a Turnaround After Losing -31.83% in 4 Weeks
Other News for GALT
GALT Crossed Above 20 Day Moving Average on September 17
GALT Fell Below 20 Day Moving Average on September 16
20 Day Moving Average Support appears for GALT after 16.2% move
12 Health Care Stocks Moving In Monday's After-Market Session
New 52 Week High appears for GALT after 9.6% move